SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001479290-19-000081
Filing Date
2019-07-18
Accepted
2019-07-18 20:25:11
Documents
2
Period of Report
2019-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_156349589534354.html 3  
1 FORM 3 wf-form3_156349589534354.xml 3 1671
2 NOLET POA ex-24.htm EX-24 3635
  Complete submission text file 0001479290-19-000081.txt   6653
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Nolet Chris (Reporting) CIK: 0001782814 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 19962217